AU2002246152A1 - Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases - Google Patents
Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseasesInfo
- Publication number
- AU2002246152A1 AU2002246152A1 AU2002246152A AU2002246152A AU2002246152A1 AU 2002246152 A1 AU2002246152 A1 AU 2002246152A1 AU 2002246152 A AU2002246152 A AU 2002246152A AU 2002246152 A AU2002246152 A AU 2002246152A AU 2002246152 A1 AU2002246152 A1 AU 2002246152A1
- Authority
- AU
- Australia
- Prior art keywords
- medicament
- utilization
- prevention
- preparation
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000010099 disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000002062 proliferating Effects 0.000 title 1
- 150000003219 pyrazolines Chemical class 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP200100818 | 2001-04-06 | ||
| ES200100818A ES2174757B1 (en) | 2001-04-06 | 2001-04-06 | EMPLOYMENT OF FIRAZOLIN DERIVATIVES IN THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION AND / OR TREATMENT OF CELLULAR PROLIFERATIVE DISEASES. |
| PCT/ES2002/000137 WO2002080909A1 (en) | 2001-04-06 | 2002-03-21 | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002246152A1 true AU2002246152A1 (en) | 2003-04-10 |
| AU2002246152B2 AU2002246152B2 (en) | 2007-05-31 |
Family
ID=8497370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002246152A Ceased AU2002246152B2 (en) | 2001-04-06 | 2002-03-21 | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20040034082A1 (en) |
| EP (2) | EP1516621A3 (en) |
| JP (1) | JP4451599B2 (en) |
| KR (1) | KR20040025912A (en) |
| CN (2) | CN1299682C (en) |
| AT (1) | ATE326966T1 (en) |
| AU (1) | AU2002246152B2 (en) |
| BR (1) | BR0208805A (en) |
| CA (1) | CA2442974C (en) |
| CY (1) | CY1105523T1 (en) |
| DE (1) | DE60211681T2 (en) |
| DK (1) | DK1384477T3 (en) |
| ES (2) | ES2174757B1 (en) |
| HK (1) | HK1067311A1 (en) |
| HU (1) | HUP0400918A3 (en) |
| IL (1) | IL158269A0 (en) |
| IS (1) | IS6973A (en) |
| MA (1) | MA27019A1 (en) |
| MX (1) | MXPA03009124A (en) |
| NO (1) | NO20034470L (en) |
| NZ (1) | NZ529304A (en) |
| PL (1) | PL365220A1 (en) |
| PT (1) | PT1384477E (en) |
| RU (1) | RU2305545C2 (en) |
| UA (1) | UA75402C2 (en) |
| WO (1) | WO2002080909A1 (en) |
| ZA (1) | ZA200308626B (en) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0507718A (en) * | 2004-02-16 | 2007-07-03 | Esteve Labor Dr | Pyrazoline derivatives useful for cancer treatment |
| ES2238923B1 (en) * | 2004-02-16 | 2006-11-01 | Laboratorios Del Dr. Esteve, S.A. | NEW SUBSTITUTED PIRAZOLINIC DERIVATIVES. |
| EP1637522A1 (en) * | 2004-09-16 | 2006-03-22 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds for reducing triglycerides in blood |
| KR20060135815A (en) * | 2004-02-17 | 2006-12-29 | 라보라토리오스 델 드라. 에스테브.에스.에이. | Substituted pyrazoline compounds for reducing triglycerides in blood |
| TW200533657A (en) | 2004-02-17 | 2005-10-16 | Esteve Labor Dr | Substituted pyrazoline compounds, their preparation and use as medicaments |
| US7998996B2 (en) | 2004-02-17 | 2011-08-16 | Laboratorios Del Dr. Esteve S.A. | Substituted pyrazoline compounds for reducing triglycerides in blood |
| EP1743892A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios del Dr. Esteve S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1849784A1 (en) * | 2006-04-26 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Indoline-substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1743637A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| US7897589B2 (en) | 2005-07-15 | 2011-03-01 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, their preparation and use as medicaments |
| WO2007009702A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| EP1849776A1 (en) * | 2006-04-26 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Azepane- or Azocane-substituted pyrazoline compounds, their preparation and use as medicaments |
| EP1743642A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
| ES2327203B1 (en) * | 2005-07-15 | 2010-06-07 | Laboratorios Del Dr. Esteve, S.A. | USE OF SUBSTITUTED PIRAZOLINE COMPOUNDS FOR THE TREATMENT OF COAGULATION-RELATED DISORDERS. |
| WO2007009704A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| EP1749527A1 (en) * | 2005-07-15 | 2007-02-07 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of the lipid parameters of the metabolic syndrome |
| WO2007009699A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A | Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases |
| WO2007009706A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| EP1743889A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios del Dr. Esteve S.A. | Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| ES2319074B1 (en) * | 2005-07-15 | 2009-12-03 | Laboratorios Del Dr. Esteve, S.A. | COMBINATION OF ACTIVE PRINCIPLES. |
| ES2326724B1 (en) * | 2005-07-15 | 2010-05-11 | Laboratorios Del Dr. Esteve, S.A. | NEW FORMULATIONS OF SUBSTITUTED PIRAZOLINA COMPOUNDS. |
| EP1743643A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | New formulations of substituted pyrazoline compounds |
| EP1743636A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Combination of a substituted pyrazoline compound and a drug used in food-related disorders |
| EP1749526A1 (en) * | 2005-07-15 | 2007-02-07 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes |
| EP1743639A1 (en) * | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazoline compounds for the treatment of coagulation related diseases |
| ES2316306B1 (en) * | 2005-07-15 | 2009-11-23 | Laboratorios Del Dr. Esteve, S.A. | COMBINATION OF A SUBSTITUTED PIRAZOLINE COMPOUND AND A PHARMACO USED IN FOOD-RELATED DISORDERS. |
| EP1746090A1 (en) * | 2005-07-15 | 2007-01-24 | Laboratorios del Dr. Esteve S.A. | Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| WO2007009701A2 (en) * | 2005-07-15 | 2007-01-25 | Laboratorios Del Dr. Esteve, S.A. | Use of substituted pyrazole compounds and combinations thereof for the treatment of the metabolic syndrome |
| EP1749525A1 (en) * | 2005-07-15 | 2007-02-07 | Laboratorios Del Dr. Esteve, S.A. | Combination of substituted pyrazolines and anti-addictive agent |
| ES2327379B1 (en) * | 2005-07-15 | 2010-05-28 | Laboratorios Del Dr. Esteve, S.A. | INDOLINSTITUTED PIRAZOLINE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICINES. |
| EP1743890A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments |
| ES2326857B1 (en) * | 2005-07-15 | 2010-05-11 | Laboratorios Del Dr. Esteve, S.A. | USE OF SUBSTITUTED PIRAZOLINE COMPOUNDS FOR THE TREATMENT OF LIPID PARAMETERS OF METABOLIC SYNDROME. |
| KR101457637B1 (en) * | 2012-10-24 | 2014-11-20 | 건국대학교 산학협력단 | A dihydropyrazolecarbothioamide derivative, Method of preparing the same, and anti-cancer agent comprising the same |
| CN103664785A (en) * | 2013-11-04 | 2014-03-26 | 南京大学 | Synthesis of novel dihydro-pyrazole sulfonamide derivative and application of novel dihydro-pyrazole sulfonamide derivative in anti-cancer drug |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5604253A (en) * | 1995-05-22 | 1997-02-18 | Merck Frosst Canada, Inc. | N-benzylindol-3-yl propanoic acid derivatives as cyclooxygenase inhibitors |
| US5972986A (en) * | 1997-10-14 | 1999-10-26 | G.D. Searle & Co. | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| ES2137138B1 (en) * | 1998-05-29 | 2000-09-16 | Esteve Labor Dr | DERIVATIVES OF PIRAZOLINES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICINES. |
| NZ516553A (en) * | 1999-06-16 | 2004-01-30 | Univ Temple | 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 and its preparation method |
-
2001
- 2001-04-06 ES ES200100818A patent/ES2174757B1/en not_active Expired - Fee Related
-
2002
- 2002-03-21 WO PCT/ES2002/000137 patent/WO2002080909A1/en active IP Right Grant
- 2002-03-21 ES ES02714233T patent/ES2264723T3/en not_active Expired - Lifetime
- 2002-03-21 NZ NZ529304A patent/NZ529304A/en unknown
- 2002-03-21 ZA ZA200308626A patent/ZA200308626B/en unknown
- 2002-03-21 PL PL02365220A patent/PL365220A1/en not_active Application Discontinuation
- 2002-03-21 EP EP04030751A patent/EP1516621A3/en not_active Withdrawn
- 2002-03-21 HU HU0400918A patent/HUP0400918A3/en unknown
- 2002-03-21 CN CNB028098935A patent/CN1299682C/en not_active Expired - Fee Related
- 2002-03-21 EP EP02714233A patent/EP1384477B1/en not_active Expired - Lifetime
- 2002-03-21 DE DE60211681T patent/DE60211681T2/en not_active Expired - Lifetime
- 2002-03-21 CA CA2442974A patent/CA2442974C/en not_active Expired - Fee Related
- 2002-03-21 IL IL15826902A patent/IL158269A0/en unknown
- 2002-03-21 CN CNA2005100713090A patent/CN1698602A/en active Pending
- 2002-03-21 DK DK02714233T patent/DK1384477T3/en active
- 2002-03-21 PT PT02714233T patent/PT1384477E/en unknown
- 2002-03-21 AT AT02714233T patent/ATE326966T1/en not_active IP Right Cessation
- 2002-03-21 KR KR10-2003-7013062A patent/KR20040025912A/en not_active Application Discontinuation
- 2002-03-21 RU RU2003132457/15A patent/RU2305545C2/en not_active IP Right Cessation
- 2002-03-21 AU AU2002246152A patent/AU2002246152B2/en not_active Ceased
- 2002-03-21 UA UA2003119998A patent/UA75402C2/en unknown
- 2002-03-21 BR BR0208805-3A patent/BR0208805A/en not_active IP Right Cessation
- 2002-03-21 JP JP2002578948A patent/JP4451599B2/en not_active Expired - Fee Related
- 2002-03-21 US US10/312,193 patent/US20040034082A1/en not_active Abandoned
- 2002-03-21 MX MXPA03009124A patent/MXPA03009124A/en active IP Right Grant
-
2003
- 2003-10-03 IS IS6973A patent/IS6973A/en unknown
- 2003-10-06 NO NO20034470A patent/NO20034470L/en not_active Application Discontinuation
- 2003-11-05 MA MA27382A patent/MA27019A1/en unknown
-
2004
- 2004-12-30 HK HK04110341A patent/HK1067311A1/en not_active IP Right Cessation
-
2006
- 2006-08-03 CY CY20061101088T patent/CY1105523T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002246152A1 (en) | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases | |
| HUP0400918A3 (en) | Utilization of pyrazoline derivatives in the preparation of pharmaceutical compositions for the prevention and/or treatment of proliferative cell diseases | |
| AU2002213357A1 (en) | Variant igg3 rituxan r and therapeutic use thereof | |
| AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
| AU2001259758A1 (en) | Interleukin-1 inhibitors in the treatment of diseases | |
| AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
| AU7490700A (en) | Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing | |
| AU2003259381A1 (en) | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases | |
| AU2922600A (en) | Pyridopyranoazepine derivatives, preparation and therapeutic use | |
| AU2001269314A1 (en) | Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds | |
| HUP0301333A3 (en) | Pharmaceutical superdisintegrant, process for its preparation and its use | |
| AU2003255645A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
| AU1164601A (en) | Therapeutic use and formulation | |
| AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
| AU2003232148A1 (en) | A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases | |
| AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
| AU2002247973A1 (en) | Use of epigallocatechin-3-gallate or its derivatives in the prevention and treatment of neurodegenerative diseases | |
| AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
| AU2000275035A1 (en) | Therapeutic and prophylactic drugs of myopia | |
| AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
| AU2001262741A1 (en) | Medicines for the prevention and treatment of neurodegenerative diseases | |
| SI1384477T1 (en) | Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases | |
| AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2002311141A1 (en) | The use of hydrochloric acid in the preparation of a medicament for the treatment of tumour | |
| AU2001262520A1 (en) | Combined preparation for the treatment of neoplasic diseases |